Found: 29
Select item for more details and to access through your institution.
Malignant melanoma with osteosarcomatous differentiation in a lymph node metastasis.
- Published in:
- Journal of Cutaneous Pathology, 2018, v. 45, n. 9, p. 701, doi. 10.1111/cup.13283
- By:
- Publication type:
- Article
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0601-9
- By:
- Publication type:
- Article
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. 1, doi. 10.1186/s13046-018-0800-9
- By:
- Publication type:
- Article
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. e38, doi. 10.1111/bjh.17197
- By:
- Publication type:
- Article
Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
- By:
- Publication type:
- Article
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 561, doi. 10.1111/bjh.14669
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 131, doi. 10.1111/bjh.13275
- By:
- Publication type:
- Article
Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e346, doi. 10.1111/ajco.13742
- By:
- Publication type:
- Article
Comparison of two leukocytapheresis protocols in a case of idiopathic hypereosinophilic syndrome.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 5, p. 481, doi. 10.1002/jca.21435
- By:
- Publication type:
- Article
Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 638, doi. 10.1002/ajh.26523
- By:
- Publication type:
- Article
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E243, doi. 10.1002/ajh.26178
- By:
- Publication type:
- Article
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E137, doi. 10.1002/ajh.26109
- By:
- Publication type:
- Article
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 7, p. 1, doi. 10.1002/ardp.201700369
- By:
- Publication type:
- Article
Discovery of 4-(Piperazin-1-yl)-7 H-pyrrolo[2,3-d]pyrimidine Derivatives as Akt Inhibitors.
- Published in:
- Archiv der Pharmazie, 2016, v. 349, n. 5, p. 356, doi. 10.1002/ardp.201500427
- By:
- Publication type:
- Article
<sup>68</sup>Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy.
- Published in:
- Cancer Biology & Medicine, 2019, v. 16, n. 1, p. 157, doi. 10.20892/j.issn.2095-3941.2018.0288
- By:
- Publication type:
- Article
Smoldering mantle cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0652-8
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0298-1
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
- By:
- Publication type:
- Article
Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e2012534, doi. 10.1001/jamanetworkopen.2020.12534
- By:
- Publication type:
- Article
Elotuzumab for the treatment of multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0284-z
- By:
- Publication type:
- Article
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0283-0
- By:
- Publication type:
- Article
Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences.
- Published in:
- Cancer Communications, 2023, v. 43, n. 10, p. 1164, doi. 10.1002/cac2.12467
- By:
- Publication type:
- Article
Frontline Treatment for Older Patients with Mantle Cell Lymphoma.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1337, doi. 10.1634/theoncologist.2017-0470
- By:
- Publication type:
- Article
Acute Myeloid Leukemia Genetics.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2015, v. 139, n. 10, p. 1215, doi. 10.5858/arpa.2015-0203-RA
- By:
- Publication type:
- Article
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2016, v. 108, n. 3, p. 1, doi. 10.1093/jnci/djv342
- By:
- Publication type:
- Article
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-17997-6
- By:
- Publication type:
- Article